CHEK2, checkpoint kinase 2, 11200

N. diseases: 297; N. variants: 261
Disease: Breast Cancer, Familial ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0346153
Disease: Breast Cancer, Familial
Breast Cancer, Familial 		0.400 GeneticVariation disease BEFREE CHEK2 1100delC is prevalent in Swedish early onset familial breast cancer. 17705858 2007
CUI: C0346153
Disease: Breast Cancer, Familial
Breast Cancer, Familial 		0.400 GeneticVariation disease BEFREE CHEK2 1100delC was genotyped in the index cases of 369 Dutch colorectal cancer families that had been excluded for familial breast cancer. 18676774 2008
CUI: C0346153
Disease: Breast Cancer, Familial
Breast Cancer, Familial 		0.400 GeneticVariation disease BEFREE CHEK2 gene mutations occur in a subset of patients with familial breast cancer, acting as moderate/low penetrance cancer susceptibility alleles. 21562711 2011
CUI: C0346153
Disease: Breast Cancer, Familial
Breast Cancer, Familial 		0.400 GeneticVariation disease BEFREE A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer. 12094328 2002
CUI: C0346153
Disease: Breast Cancer, Familial
Breast Cancer, Familial 		0.400 Biomarker disease CLINGEN A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer. 12094328 2002
CUI: C0346153
Disease: Breast Cancer, Familial
Breast Cancer, Familial 		0.400 GeneticVariation disease BEFREE A novel CHEK2 variant identified by next generation sequencing in an Indian family with hereditary breast cancer syndrome. 31296309 2019
CUI: C0346153
Disease: Breast Cancer, Familial
Breast Cancer, Familial 		0.400 Biomarker disease CLINGEN A risk of breast cancer in women - carriers of constitutional CHEK2 gene mutations, originating from the North - Central Poland. 24713400 2014
CUI: C0346153
Disease: Breast Cancer, Familial
Breast Cancer, Familial 		0.400 GeneticVariation disease BEFREE Breast cancer low-penetrance allele 1100delC in the CHEK2 gene: not present in the Chinese familial breast cancer population. 18484200 2008
CUI: C0346153
Disease: Breast Cancer, Familial
Breast Cancer, Familial 		0.400 Biomarker disease CLINGEN Breast tumors from CHEK2 1100delC-mutation carriers: genomic landscape and clinical implications. 21542898 2011
CUI: C0346153
Disease: Breast Cancer, Familial
Breast Cancer, Familial 		0.400 Biomarker disease BEFREE Compared with control datasets, predicted damaging rare missense variants were significantly more prevalent in CHEK2 and TP53 in BC index patients. 29522266 2018
CUI: C0346153
Disease: Breast Cancer, Familial
Breast Cancer, Familial 		0.400 GeneticVariation disease BEFREE Computational analysis of high-risk SNPs in human CHK2 gene responsible for hereditary breast cancer: A functional and structural impact. 31398194 2019
CUI: C0346153
Disease: Breast Cancer, Familial
Breast Cancer, Familial 		0.400 Biomarker disease CLINGEN Concomitant inactivation of p53 and Chk2 in breast cancer. 11857075 2002
CUI: C0346153
Disease: Breast Cancer, Familial
Breast Cancer, Familial 		0.400 Biomarker disease CLINGEN DNA damage-induced activation of p53 by the checkpoint kinase Chk2. 10710310 2000
CUI: C0346153
Disease: Breast Cancer, Familial
Breast Cancer, Familial 		0.400 GeneticVariation disease BEFREE First evidence of a large CHEK2 duplication involved in cancer predisposition in an Italian family with hereditary breast cancer. 24986639 2014
CUI: C0346153
Disease: Breast Cancer, Familial
Breast Cancer, Familial 		0.400 GeneticVariation disease BEFREE Genotyping for the CHEK2∗1100delC mutation in a familial breast cancer setting contributes to optimal clinical surveillance in countries in which this mutation is prevalent. 23415889 2013
CUI: C0346153
Disease: Breast Cancer, Familial
Breast Cancer, Familial 		0.400 GeneticVariation disease BEFREE Germ line CHEK2 mutations are seen in a subset of patients with a familial breast cancer and sarcoma phenotype. 24595525 2014
CUI: C0346153
Disease: Breast Cancer, Familial
Breast Cancer, Familial 		0.400 Biomarker disease CLINGEN hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response. 10724175 2000
CUI: C0346153
Disease: Breast Cancer, Familial
Breast Cancer, Familial 		0.400 Biomarker disease BEFREE Hence, our approach allowed us to specify BC relative risks associated with deleterious-predicted variants in PALB2, ATM and CHEK2 and to add MAST1, POLH, RTEL1 and FANCI to the list of DNA repair genes possibly involved in BC susceptibility. 30303537 2019
CUI: C0346153
Disease: Breast Cancer, Familial
Breast Cancer, Familial 		0.400 Biomarker disease BEFREE Here, we briefly outline the molecular properties, regulation and physiological role of CHEK2, and review in more detail its defects that predispose to tumors, with particular emphasis on familial breast cancer. 16998506 2006
CUI: C0346153
Disease: Breast Cancer, Familial
Breast Cancer, Familial 		0.400 GeneticVariation disease BEFREE However, only about 20% of familial breast cancer is attributed to mutations in BRCA1 and BRCA2, while a further 5-10% are attributed to mutations in other rare susceptibility genes such as TP53, STK11, PTEN, ATM and CHEK2. 25736863 2015
CUI: C0346153
Disease: Breast Cancer, Familial
Breast Cancer, Familial 		0.400 GeneticVariation disease BEFREE However, only about 20% of familial breast cancer cases are attributed to mutations in BRCA1 and BRCA2, while a further 5-10% are attributed to mutations in other rare susceptibility genes such as TP53, STK11, PTEN, ATM and CHEK2. 25936246 2015
CUI: C0346153
Disease: Breast Cancer, Familial
Breast Cancer, Familial 		0.400 Biomarker disease CLINGEN Increased Risk for Other Cancers in Addition to Breast Cancer for CHEK2*1100delC Heterozygotes Estimated From the Copenhagen General Population Study. 26884562 2016
CUI: C0346153
Disease: Breast Cancer, Familial
Breast Cancer, Familial 		0.400 GeneticVariation disease BEFREE Mutations in the recognized breast cancer susceptibility genes BRCA1, BRCA2, TP53, ATM, and CHEK2 account for approximately 20% of hereditary breast cancer. 21409391 2011
CUI: C0346153
Disease: Breast Cancer, Familial
Breast Cancer, Familial 		0.400 Biomarker disease BEFREE One gene that is commonly included on NGS hereditary breast cancer panels is CHEK2. 25355026 2014
CUI: C0346153
Disease: Breast Cancer, Familial
Breast Cancer, Familial 		0.400 Biomarker disease CLINGEN PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS. 27595995 2016